Showing results (1901-1910 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Effects of injection routes of growing tumors and PSK or OK-432 on antiproliferative activity of mouse serumC Ryoyama, K Ryoyama
Cancer Immunology, Immunotherapy : CII|September 18, 2015
RNA and protein expression of herpesvirus entry mediator (HVEM) is associated with molecular markers, immunity-related pathways and relapse-free survival of patients with AMLFelix S Lichtenegger, Isabell Kondla, Michael Krempasky, et al.
Cancer Immunology, Immunotherapy : CII|September 18, 2015
Immunotherapy with dendritic cells loaded with glioblastoma stem cells: from preclinical to clinical studiesGaetano Finocchiaro, Serena Pellegatta
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Intratumour factors influencing the access of antibody to tumour cellsL M Cobb
Cancer Immunology, Immunotherapy : CII|April 8, 2016
Immunogenicity and efficacy of the novel cancer vaccine based on simian adenovirus and MVA vectors alone and in combination with PD-1 mAb in a mouse model of prostate cancerFederica Cappuccini, Stephen Stribbling, Emily Pollock, et al.
Cancer Immunology, Immunotherapy : CII|April 8, 2016
Designing therapeutic cancer vaccines by mimicking viral infectionsHussein Sultan, Valentyna I Fesenkova, Diane Addis, et al.
Cancer Immunology, Immunotherapy : CII|March 23, 2016
Non-small-cell lung cancer-induced immunosuppression by increased human regulatory T cells via Foxp3 promoter demethylationXing Ke, Shuping Zhang, Jian Xu, et al.
Cancer Immunology, Immunotherapy : CII|April 25, 2016
How frequently are predicted peptides actually recognized by CD8 cells?Ioana Moldovan, Oleg Targoni, Wenji Zhang, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
A preliminary pharmacokinetic study of 111In-labeled 260F9 anti-(breast cancer) antibody in patientsT W Griffin, F Bokhari, J Collins, et al.
Cancer Immunology, Immunotherapy : CII|August 21, 2015
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemiasGabriella Pietra, Chiara Vitale, Daniela Pende, et al.
Pageof 652